More than four years after the Affordable Care Act’s enactment and more than a month after the close of open enrollment, six in 10 Americans say the health reform law has not had an impact on them or their families, Kaiser’s May Tracking Poll finds. Among those who say it has, Republicans are much more likely to say their families have been hurt by the law than helped, while Democrats are more likely to say their families have been helped than hurt.
- state & global data
- view as grid
- view as list
Drew Altman, in The Wall Street Journal’s Think Tank, discusses the push by Conservative House Republicans for a vote on a GOP health care plan and uses public opinion polling to explain the push as an appeal to the Republican base in an election year.
In this column for The Wall Street Journal’s Think Tank, Drew Altman lays out the news media’s challenge covering the upcoming Supreme Court King v. Burwell decision about the ACA.
Larry Levitt’s March 2015 post explores what could happen if the U.S. Supreme Court rules for the plaintiffs in the King v. Burwell case, the lawsuit that challenges the federal government’s authority to provide financial assistance to people who buy insurance in federally-operated marketplaces created by the Affordable Care Act.
Poll Finds Nearly Three Quarters of Americans Say Prescription Drug Costs Are Unreasonable, and Most Blame Drug Makers Rather Than Insurers for the Problem
If Supreme Court’s King v. Burwell Decision Restricts Insurance Subsidies to Certain States, Most Say Congress Should Act to Ensure Residents of All States are Eligible, and a Majority in Potentially Affected States say Their State Should Act Public’s Views on Affordable Care Act Are Divided and Unchanged: 42% Unfavorable…
With a Supreme Court decision on King v. Burwell looming, this Drew Altman column for The Wall Street Journal’s Think Tank plays out the politics of a ruling for the two major parties.
With the Supreme Court ruling on King v. Burwell upholding the Affordable Care Act’s federal subsidies, Drew Altman’s column in The Wall Street Journal’s Think Tank explores what the decision means and what’s next for the health law.
In this column for The Wall Street Journal’s Think Tank, Drew Altman finds the public’s healthcare priorities have more to do with drug costs and other real world issues people deal with using the health care system than the ongoing partisan wrangling over the Affordable Care Act (ACA).
In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses whether the debate about the Iran deal may bring a respite for the Affordable Care Act from politics as usual, and how long it might last.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses whether the debate about the Iran deal may bring a respite for the Affordable Care Act from politics as usual, and how long it might last. All previous columns by Drew Altman are available.